REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact
The Workpackages
- Steering committee. Project coordinator
- European Commission
- Scientific advisory board
- Scientific advisory board
- WP6: Project and IP Management
- WP1: Antigen identification and vaccine design
- WP2: Antigen and antibody production and delivery platforms
- WP3: Evaluation of vaccine antigen formulation in vivo
- WP4: Specific diagnostic tests and DIVA strategies
- WP5: Stakeholder engagement. Dissemination, exploitation and communication
REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.
REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.